SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nureca informs about filing of scheme

24 Jul 2025 Evaluate
Nureca has informed that in furtherance to communication dated May 20, 2025, wherein the Company had intimated that the Board of Directors of Nureca (Transferee Company) at its meeting held on May 20, 2025, subject to requisite approvals / consents, approved the Draft Scheme of Merger by absorption of Nureca Technologies (Transferor Company), being the wholly owned subsidiary of the Company, with and into the Company pursuant to Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 (Act) and rules framed thereunder and in terms of Regulations 37(6) of the SEBI Listing Regulations read with SEBI Master Circular No. SEBI/HO/CFD/POD-2/P/CIR/2023/93 dated June 20, 2023 (SEBI Circular), the requirement of obtaining ‘No Objection Letter’ from the Stock Exchange is not applicable to draft schemes which solely provide for merger of a wholly owned subsidiary with its holding company. However, in accordance with the provisions of Regulations 37(6) of the SEBI Listing Regulations read with the SEBI Circular, such schemes shall be filed with the stock exchanges for the purpose of disclosures and the stock exchanges shall disseminate the scheme documents on their websites. Accordingly, they submitted the following documents for dissemination on the websites of stock exchanges: a. Copy of Scheme of Merger of Transferor Company with and into the Company pursuant to Sections 230 to 232 and other applicable provisions of the Act and rules framed thereunder (Scheme); b. Outcome of the Board Meeting held on 20th May, 2025 approving the Draft Scheme of merger of Transferor Company, with the Company, which was submitted to the Stock Exchanges vide letter dated 20th May, 2025; c. Certified True Copy of the Extract of the Resolution passed by the Board of Directors of the Company and the Transferor Companies dated 20th May, 2025.

The above information is a part of company’s filings submitted to BSE. 

Nureca Ltd. Share Price

286.00 -3.30 (-1.14%)
11-May-2026 14:27 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 490.40
Poly Medicure 1644.80
Laxmi Denta 216.10
Nureca Ltd. 286.00
Hemant Surgical Inds 361.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×